Federal Health Grants

This grant provides funding for researchers to explore how the human microbiome influences immune responses to prevent cancer, aiming to identify new strategies for cancer prevention.

This funding opportunity supports research into innovative non-invasive brain stimulation techniques to treat substance use disorders, targeting under-explored brain areas and measuring treatment success indicators.

This funding opportunity supports research institutions and organizations in developing new drugs to prevent, slow, or treat Alzheimer's disease through early-stage and preclinical studies.

This funding opportunity supports projects that promote inclusive economic growth and human development in Equatorial Guinea, encouraging collaboration between local and U.S. organizations, individuals, and educational institutions.

This funding opportunity provides financial support to state and local governments, nonprofit organizations, and educational institutions to improve the collection and use of health data, particularly focusing on addressing health disparities in underserved communities across the U.S.

This grant provides funding for U.S.-based institutions to conduct economic research and develop tools that improve interventions for substance use disorder within the criminal-legal system, ultimately aiming to reduce overdose risks.

The purpose of this Funding Opportunity Announcement (FOA) is to invite R01 applications on chronic conditions understudied among women and/or that disproportionately affect populations of women who are understudied, underrepresented, and underreported in biomedical Research should align with Goal 1 of the 2019-2023 Trans-NIH Strategic Plan for Women's Health Research "Advancing Science for the Health of Women." The awards under this FOA will be administered by NIH ICs using funds that have been made available through the Office of Research on Womens Health (ORWH) and the scientific partnering Institutes and Centers across NIH.

This funding opportunity supports researchers in developing and validating assays to discover new chemical compounds that could lead to treatments for mental health disorders.

This grant provides funding for researchers to evaluate and develop effective strategies to prevent driving under the influence of multiple substances, particularly focusing on high-risk populations.

This funding opportunity provides financial support to nonprofit organizations for developing and implementing community-based substance use prevention programs targeting youth in schools and extracurricular settings.

This funding opportunity provides financial support to organizations working with Eswatini's Ministry of Health to strengthen its capacity in managing and responding to HIV, TB, and related public health challenges.

This funding opportunity is designed to support the creation and maintenance of a user-friendly online platform that provides essential HIV care resources and tools for healthcare providers, program recipients, and the general public.

To All Interested Parties:The United States Agency for International Development Mission in Madagascar (USAID/Madagascar) is publishing this Request for Information (RFI) to obtain inputs from all interested organizations regarding a potential activity design to advance the Government of Madagascars national digital health capacity to plan, govern, and implement national digital health and health information systems strategies and architecture to optimize the availability, quality, and use of information to achieve national public health goals. The obtained information may be used to help make planning decisions and may inform activity design to improve future development outcomes, but is solely for market research purposes. All types of organizations and firms are strongly encouraged to submit a response, including local organizations and small businesses.Through this RFI, USAID seeks ideas, comments, and information from the public that will assist in developing an activity that will most effectively advance the topic areas described above. Please note that responding to this RFI will not give any advantage to or preclude any organization/individual from any solicitation that may be issued in the future, as any/all comments received will be for information gathering purposes only. Issuance of this RFI does not constitute a solicitation and it does not represent an award commitment on the part of USAID, nor does it obligate USAID to pay for costs incurred in the preparation and submission of any comments.

This funding provides financial support to U.S. states and territories to ensure low-income individuals living with HIV have uninterrupted access to necessary medications and healthcare coverage.

This funding opportunity provides financial support for developing short courses that equip nurse scientists and researchers with the skills needed to advance firearm injury prevention research, focusing on health equity and innovative methodologies.

This funding opportunity provides financial support for researchers to analyze existing health datasets related to heart, lung, and blood diseases, as well as sleep disorders, in order to address important scientific questions and improve health outcomes.

This funding opportunity provides up to $500,000 for researchers to conduct innovative studies that inform tobacco product regulation and public health, with a focus on understanding tobacco use, its health effects, and addiction.

Reissue of RFA-NS-18-020: Understanding the dynamic activity of brain circuits is central to the NIH BRAIN Initiative. This FOA seeks applications for proof-of-concept testing and development of new technologies and novel approaches for recording and modulation (including various modalities for stimulation/activation, inhibition and manipulation) of cells (i.e., neuronal and non-neuronal) and networks to enable transformative understanding of dynamic signaling in the central nervous system (CNS). This FOA seeks exceptionally creative approaches to address major challenges associated with recording and modulating CNS activity, at or near cellular resolution, at multiple spatial and/or temporal scales, in any region and throughout the entire depth of the brain. It is expected that the proposed research may be high-risk, but if successful, could profoundly change the course of neuroscience research. Proposed technologies should be compatible with experiments in behaving animals, validated under in vivo experimental conditions, and capable of reducing major barriers to conducting neurobiological experiments and making new discoveries about the CNS. Technologies may engage diverse types of signaling beyond neuronal electrical activity such as optical, magnetic, acoustic and/or genetic recording/manipulation. Applications that seek to integrate multiple approaches are encouraged. If suitable, applications are expected to integrate appropriate domains of expertise, including biological, chemical and physical sciences, engineering, computational modeling and statistical analysis.

This funding opportunity supports collaborative research projects led by independent investigators to advance the understanding and treatment of infectious and immune-mediated diseases.

Rapid advances in genotyping and next generation sequencing technologies have led to the identification of genetic variants that are associated with a wide variety of congenital defects including structural birth defects (SBDs), intellectual developmental disabilities (IDDs) and inborn errors of metabolism (IEMs). Large quantities of genomic data collected from pediatric birth defects cohorts are available to the research community through several databases such as the Database of Genotypes and Phenotypes (dbGaP), the Gabriella Miller Kids First Data Resource Portal, the European Genome-Phenome Archive and Clinical Genome Resource (ClinGen). The purpose of this initiative is to promote the screening, functional validation and characterization of birth defects-associated genetic variants identified through public facing databases and individual efforts using in-silico tools, appropriate animal models, in vitro systems or multi-pronged approaches. This initiative addresses a challenging gap between identifying sequence variations of potential interest and recognizing which of those variations have functional effects on the phenotype of interest.